248 related articles for article (PubMed ID: 10667813)
21. Lymph node metastasis in early gastric cancer: how can surgeons perform limited surgery?
Yokota T; Saito T; Teshima S; Kikuchi S; Kunii Y; Yamauchi H
Int Surg; 1998; 83(4):287-90. PubMed ID: 10096743
[TBL] [Abstract][Full Text] [Related]
22. [Therapeutic effects of transabdominal radical total gastrectomy on cardiac cancer: analysis of 56 cases].
Wu T; Wan YL; Rong L; Pan YS; Wang X; Liu YC
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1474-7. PubMed ID: 17785085
[TBL] [Abstract][Full Text] [Related]
23. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
[TBL] [Abstract][Full Text] [Related]
24. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
25. Survival analysis after surgical treatment of gastric cancer: review of 121 cases.
Nazli O; Derici H; Tansug T; Yaman I; Bozdag AD; Isgüder AS; Bölükbasi H
Hepatogastroenterology; 2007 Mar; 54(74):625-9. PubMed ID: 17523337
[TBL] [Abstract][Full Text] [Related]
26. Surgical outcome in early gastric cancer with lymph node metastasis.
Hanazaki K; Wakabayashi M; Sodeyama H; Makiuchi A; Igarashi J; Yokoyama S; Sode Y; Kawamura N; Ohtsuka M; Miyazaki T
Hepatogastroenterology; 1997; 44(15):907-11. PubMed ID: 9222713
[TBL] [Abstract][Full Text] [Related]
27. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer.
Asoglu O; Karanlik H; Parlak M; Kecer M; Muslumanoglu M; Igci A; Ozmen V; Gulluoglu M; Kapran Y
Hepatogastroenterology; 2009; 56(91-92):908-13. PubMed ID: 19621727
[TBL] [Abstract][Full Text] [Related]
28. [The most important prognostic factors for 736 patients with adenocarcinoma of the gastric cardia: a multivariate analysis using COX proportion hazard model].
Li J; Zhang R; Zhang D
Zhonghua Zhong Liu Za Zhi; 1996 Mar; 18(2):134-6. PubMed ID: 9206048
[TBL] [Abstract][Full Text] [Related]
29. Biologic predictors of survival in node-negative gastric cancer.
Kooby DA; Suriawinata A; Klimstra DS; Brennan MF; Karpeh MS
Ann Surg; 2003 Jun; 237(6):828-35; discussion 835-7. PubMed ID: 12796579
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for patients with node-negative gastric cancer: Can extended lymph node dissection have a survival benefit?
Park SS; Park JM; Kim JH; Kim WB; Lee J; Kim SJ; Kim CS; Mok YJ
J Surg Oncol; 2006 Jul; 94(1):16-20. PubMed ID: 16788938
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic features of the patients with node-negative metastasis gastric adenocarcinoma and their survival analysis].
Li J; Cai SR; He YL; Huang MJ; Mei KY; Wang JP; Zhan WH
Zhonghua Wei Chang Wai Ke Za Zhi; 2006 May; 9(3):230-3. PubMed ID: 16721684
[TBL] [Abstract][Full Text] [Related]
32. Results of immunochemo-surgery for gastric carcinoma.
Kim JP; Yu HJ; Lee JH
Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
[TBL] [Abstract][Full Text] [Related]
33. The significance of perineural invasion as a prognostic factor in patients with gastric carcinoma.
Duraker N; Sişman S; Can G
Surg Today; 2003; 33(2):95-100. PubMed ID: 12616368
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal carcinomatosis and lymph node metastasis are prognostic indicators in patients with Borrmann type IV gastric carcinoma.
Chen CY; Wu CW; Lo SS; Hsieh MC; Lui WY; Shen KH
Hepatogastroenterology; 2002; 49(45):874-7. PubMed ID: 12064011
[TBL] [Abstract][Full Text] [Related]
35. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
36. Multivariate prognostic study on node-positive gastric cancer: is tumor size a prognostic indicator?
Liu Y; Chen XH; Meng XH; Liu CF; Zhao LL; Han JW; Zhuang LW
Hepatogastroenterology; 2012; 59(114):623-6. PubMed ID: 22024039
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathology and prognosis of mucinous gastric carcinoma.
Hidaka S; Tanaka K; Takeshita H; Sumida Y; Fukuoka H; Abo T; Yano H; Nanashima A; Sawai T; Yasutake T; Nagayasu T
Hepatogastroenterology; 2008; 55(82-83):791-4. PubMed ID: 18613456
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in a series of 297 patients with gastric adenocarcinoma undergoing surgical resection.
Sánchez-Bueno F; Garcia-Marcilla JA; Perez-Flores D; Pérez-Abad JM; Vicente R; Aranda F; Ramirez P; Parrilla P
Br J Surg; 1998 Feb; 85(2):255-60. PubMed ID: 9501830
[TBL] [Abstract][Full Text] [Related]
40. Prediction of survival time after curative surgery for advanced gastric cancer.
Moriguchi S; Maehara Y; Korenaga D; Sugimachi K; Hayashi Y; Nose Y
Eur J Surg Oncol; 1992 Jun; 18(3):287-92. PubMed ID: 1607042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
